Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
456 Views
Emedinexus 22 June 2025
The FDA has approved an Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate extended-release oral capsules, a treatment commonly used for overactive bladder.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}